Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Bulgaria Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20083
20092
20103
20113
20124
20142
20151
20161
20171
20181
20191
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Chiesi Farmaceutici S.p.A.3
GlaxoSmithKline3
Pfizer3
Mereo BioPharma2
Genentech, Inc.1
Hoffmann-La Roche1
MedImmune LLC1
Novartis Pharmaceuticals1
Sosei1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive28
Emphysema3
Respiration Disorders3
Bronchitis, Chronic2
Lung Diseases2
Pneumonia2
Asthma1
Bronchiolitis Obliterans Syndrome1
Lung Diseases, Obstructive1
Respiratory Aspiration1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.